Dr. Reddy's Aurigene Discovery Technologies Ltd. subsidiary grants Debiopharm exclusive, worldwide rights to Debio 1142 to treat solid tumors

Dr. Reddy's Laboratories Ltd.

India / Mid-Cap Biopharma ($1-$50 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Debiopharm Group

Switzerland / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced